A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein-Reference-Cited by-同舟云学术

A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein

Published:2018-08-13 Issue:8 Volume:13 Page:e0201764
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Otsuki Noriko^ORCID,Arakawa Reiko,Kaneko Kaori,Aoki Ryoko,Arakawa Masayuki,Saito Kayoko

Funder

the Japan Agency for Medical Research and Development

JSPS Grants-in-Aid for Scientific Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Identification and characterization of a spinal muscular atrophy-determining gene;S Lefebvre;Cell,1995

2. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications;K Zerres;Arch Neurol,1995

3. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy;CL Lorson;Proc Natl Acad Sci U S A,1999

4. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2;UR Monani;Hum Mol Genet,1999

5. Regulation of SMN protein stability;BG Burnett;Mol Cell Biol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers;Neurology and Therapy;2024-05-16

2. Changes in serum parameters during nusinersen treatment in children with spinal muscular atrophy;2024-04-29

3. Neuromuscular disorders in the omics era;Clinica Chimica Acta;2024-01

4. Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review);Neuromuscular Diseases;2023-10-30

5. Enhancing In Vitro SMN Protein Expression and Cell Viability through Xeno-Nucleic Acid-Based ASOs in Spinal Muscular Atrophy;2023-08-21